Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Rod Dawson"'
Autor:
Rod Dawson, Rany Condos, Doris Tse, Maryann L Huie, Stanley Ress, Chi-Hong Tseng, Clint Brauns, Michael Weiden, Yoshihiko Hoshino, Eric Bateman, William N Rom
Publikováno v:
PLoS ONE, Vol 4, Iss 9, p e6984 (2009)
BACKGROUND:Current treatment regimens for pulmonary tuberculosis require at least 6 months of therapy. Immune adjuvant therapy with recombinant interferon-gamma1b (rIFN-gammab) may reduce pulmonary inflammation and reduce the period of infectivity by
Externí odkaz:
https://doaj.org/article/c14c2f37ebaa40438431c8e1f9f805ea
Autor:
Anthony T Podany, Michelle Pham, Erin Sizemore, Neil Martinson, Wadzanai Samaneka, Lerato Mohapi, Sharlaa Badal-Faesen, Rod Dawson, John L Johnson, Harriet Mayanja, Umesh Lalloo, William C Whitworth, April Pettit, Kayla Campbell, Patrick P J Phillips, Kia Bryant, Nigel Scott, Andrew Vernon, Ekaterina V Kurbatova, Richard E Chaisson, Susan E Dorman, Payam Nahid, Susan Swindells, Kelly E Dooley, Courtney V Fletcher
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 75, iss 4
Clin Infect Dis
Clin Infect Dis
Background A 4-month regimen containing rifapentine and moxifloxacin has noninferior efficacy compared to the standard 6-month regimen for drug-sensitive tuberculosis. We evaluated the effect of regimens containing daily, high-dose rifapentine on efa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17723c114dd6de4698d163d6fbb7ee29
https://escholarship.org/uc/item/4694p0w3
https://escholarship.org/uc/item/4694p0w3
Autor:
Richard N. van Zyl-Smit, Grant Theron, Richard Meldau, Brian Allwood, Jonny Peter, Anil Pooran, Rod Dawson, Keertan Dheda, Greg Calligaro, Surendra K. Sharma, Hridesh Mishra
Publikováno v:
European Respiratory Journal. 40:161-168
Information regarding the utility of adjunct diagnostic tests in combination with Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) is limited. We hypothesised adjunct tests could enhance accuracy and/or reduce the cost of tuberculosis (TB) diagnosis prior
Autor:
E D Bateman, Andrew Whitelaw, Helen Wainwright, Alimuddin Zumla, Motasim Badri, Y Vallie, Keertan Dheda, Leonardo Antonio Sechi, Alice Maredza, P Raubenheimer, S Meldau, Greg Symons, Rod Dawson, Patrick L. Semple, R Meldau, R N van Zyl-Smit
Publikováno v:
European Respiratory Journal. 34:1118-1126
The clinical utility of antigen-specific interferon (IFN)-gamma release assays (IGRAs) using pleural mononuclear cells, for the diagnosis of tuberculosis (TB), requires clarification. We compared the diagnostic utility of unstimulated pleural IFN-gam
Autor:
Richard Pine, Michael D. Weiden, Stanley R. Ress, Yoshihiko Hoshino, Ilana Belitskaya-Levy, Jeffrey A. Gold, B. Raju, Anna Nolan, William N. Rom, Rod Dawson, Stuart M. Brown, Rany Condos
Publikováno v:
Tuberculosis. 88:39-51
The host response to Mycobacterium tuberculosis includes macrophage activation, inflammation with increased immune effector cells, tissue necrosis, and cavity formation, and fibrosis, distortion, and bronchiectasis. To evaluate the molecular basis of
Publikováno v:
Public Health Action. 3:4-6
The global focus on human immunodeficiency virus (HIV) infection in recent years has been on improving access to antiretroviral therapy (ART). World Health Organization (WHO) statistics indicate that in countries such as South Africa, Bangladesh, Ind
Autor:
Eric D. Bateman, Michael D. Weiden, Rod Dawson, Yoshihiko Hoshino, William N. Rom, Anna Nolan, Leopoldo N. Segal, Barbara A. Methé
Publikováno v:
Proceedings of the American Thoracic Society. 8(3)
Community-acquired pneumonia affects approximately 4 million people in the United States, with 40,000 deaths per year. The incidence is increased about 35-fold in HIV-infected individuals, and this rate has decreased since the antiretroviral era has
Autor:
Clint Brauns, Chi-Hong Tseng, Rod Dawson, Maryann L. Huie, William N. Rom, Doris B. Tse, Michael D. Weiden, Eric D. Bateman, Stanley R. Ress, Rany Condos, Yoshihiko Hoshino
Publikováno v:
PLoS ONE
PLoS ONE, Vol 4, Iss 9, p e6984 (2009)
PLoS One
PLoS ONE, Vol 4, Iss 9, p e6984 (2009)
PLoS One
BACKGROUND Current treatment regimens for pulmonary tuberculosis require at least 6 months of therapy. Immune adjuvant therapy with recombinant interferon-gamma1b (rIFN-gammab) may reduce pulmonary inflammation and reduce the period of infectivity by
Autor:
E D Bateman, R. van Zyl-Smit, Leonardo Antonio Sechi, K Dheda, Rod Dawson, R Meldau, Alimuddin Zumla, Motasim Badri
Publikováno v:
C25. DIAGNOSIS AND TREATMENT OF MYCOBACTERIAL INFECTIONS.
Publikováno v:
Clinical Microbiology and Infection. (7):711-717
The measurement of early bactericidal activity (EBA) is the first step in the clinical investigation of antituberculosis agents. EBA is determined by quantifying the viable sputum mycobacterial load on consecutive days of treatment. To investigate wh